#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Learn more about our ranking as the top pediatric hospital here.
The pace at which our understanding of the immune system—and, along with it, autoimmune diseases—has increased dramatically in the past few decades. So, too, has the pace of diagnostics and treatment.
Here at Boston Children’s Hospital, the Samara Jan Turkel Clinical Center for Pediatric Autoimmune Diseases is helping to pioneer some of the most promising new therapies for these illnesses, including the use of biologics: protein-based drugs made from living cells cultured in a lab.
Our physicians have participated in a number of multicenter studies that focus on biologics, including:
Learn more about research at Boston Children's.
There are many ways in which your child might benefit from Boston Children’s Hospital’s medical research program. Boston Children’s doctors and scientists have made many breakthrough discoveries about diseases like polio and leukemia; our ongoing research continues to push the boundaries of the way pediatric medicine is practiced.
It’s possible that your child will be eligible to participate in one of Boston Children’s current clinical trials. These studies are useful for a multitude of reasons: Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur. At any given time, Boston Children’s has hundreds of clinical trials under way.
Alternately, your child’s doctor might ask you to participate in a registry, a list of patients with JIA that is matched to an archive of biospecimens (such as serum and DNA) to serve as a resource for research into this disease.
And participation in any clinical trial or registry is completely voluntary: We’ll take care to fully explain all elements of the treatment plan prior to the start of the trial, and you may remove your child from the medical study at any time.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”